Kennedy Capital Management’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.34M Buy
474,971
+12,412
+3% +$104K 0.09% 321
2025
Q4
$3.44M Buy
462,559
+980
+0.2% +$7.04K 0.07% 359
2025
Q3
$3.09M Buy
461,579
+317,157
+220% +$2.2M 0.07% 376
2025
Q2
$956K Buy
144,422
+21,463
+17% +$152K 0.02% 512
2025
Q1
$1.13M Sell
122,959
-91,025
-43% -$909K 0.03% 496
2024
Q4
$2.25M Buy
213,984
+95,266
+80% +$1.13M 0.05% 496
2024
Q3
$1.42M Buy
118,718
+28,427
+31% +$246K 0.03% 560
2024
Q2
$519K Sell
90,291
-29,843
-25% -$164K 0.01% 637
2024
Q1
$625K Buy
120,134
+48,111
+67% +$235K 0.01% 645
2023
Q4
$380K Buy
72,023
+5,467
+8% +$21.6K 0.01% 645
2023
Q3
$220K Buy
+66,556
New +$234K 0.01% 650

Other funds holding BVS